PKC412--a protein kinase inhibitor with a broad therapeutic potential.

Fabbro, D

PKC412--a protein kinase inhibitor with a broad therapeutic potential. [electronic resource] - Anti-cancer drug design Feb 2000 - 17-28 p. digital

Publication Type: Journal Article

0266-9536


Angiogenesis Inhibitors--pharmacology
Animals
Blood Proteins--metabolism
Cell Cycle--drug effects
Clinical Trials, Phase I as Topic
Enzyme Inhibitors--metabolism
Humans
Mice
Neoplasms--drug therapy
Protein Binding
Protein Kinase C--antagonists & inhibitors
Staurosporine--analogs & derivatives
Tumor Cells, Cultured